MétaCan
Menu
← Back to cohort
Record W4281725892 · doi:10.5489/cuaj.7932

Poster Session 10: Pediatrics

2022· article· en· W4281725892 on OpenAlexvenueaboutno aff
Editor CUAJ

Bibliographic record

VenueCanadian Urological Association Journal · 2022
Typearticle
Languageen
FieldMedicine
TopicNeonatal Respiratory Health Research
Canadian institutionsnot available
Fundersnot available
KeywordsSession (web analytics)PediatricsMedicineComputer sciencePsychologyWorld Wide Web

Abstract

fetched live from OpenAlex

Introduction: Antimuscarinics are the cornerstone of the pharmacological treatment of overactive bladder (OAB) but side effects often limit their longterm use.Propiverine hydrochloride, a molecule with a mixed mechanism of action, was approved in Canada in 2017 as a therapy for OAB in adults and children.However, there is scarce data on its efficacy and tolerability in the pediatric population.Our primary objective was to assess the efficacy and tolerability of propiverine as a first-or second-line pharmacological treatment of OAB in children.Our secondary objective was to compare propiverine to other molecules already investigated in historical cohorts.Methods: We conducted a retrospective analysis of a prospectively maintained database and reviewed 58 patients who received propiverine between 2017 and 2021.Patients had to attend at least one followup visit to be included.Efficacy and tolerability were assessed through voiding diaries, postvoid residuals (PVR), and by questioning patients and families on change in the number of incontinence episodes (day and night), in urgency episodes (grade 1-3), and on reported adverse events.Categorical variables were reported as counts and percentages, and descriptive statistics (mean and standard deviation or medians and quartiles) were reported for continuous variables.Paired tests were used to assess the evolution of mean bladder capacity and expected bladder capacity (%EBC) scores at different followup points, and linear regression models with the GEE method were used to estimate their average monthly variation.Results: Fifty-eight patients (37 boys) initiated treatment at a mean age of 9.5±3.2years.Patients were on propiverine for an average of 15.9±12.4months.Mean bladder capacity increased from 120 ml to 216 ml, and %EBC increased from 37% to 59%.The average increased rate of %EBC was 0.5% per month (p<0.001).Of the 58 patients, eight were able to stop the medication completely without symptom recurrence, 21 are still on medication, and six are on dose-tapering.Due to treatment-related adverse events, seven interrupted their treatment.Compared to other molecules regularly used in our service, propiverine offered comparable efficacy and tolerability.Our study had limitations: the absence of a placebo group and its retrospective design.Conclusions: Propiverine appears to be an efficient and safe option for treating OAB in children and is approved for use in children.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: Other
Teacher disagreement score0.619
Threshold uncertainty score0.544

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0020.002
Open science0.0010.003
Research integrity0.0030.004
Insufficient payload (model declined to judge)0.6190.361

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.035
GPT teacher head0.321
Teacher spread0.286 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueCanadian Urological Association Journal→Same topicNeonatal Respiratory Health Research→French-language works237,207→